Author:
Farmakis Dimitrios,Parissis John T.,Bistola Vassiliki,Paraskevaidis Ioannis A.,Iliodromitis Efstathios K.,Filippatos Gerasimos,Kremastinos Dimitrios T.
Subject
Cardiology and Cardiovascular Medicine
Reference26 articles.
1. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial;Follath;Lancet,2002
2. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN);Moiseyev;Eur Heart J,2002
3. Packer M. REVIVE II: Multicenter placebo-controlled trial of levosimendan on clinical status in acutely decompensated heart failure. Program and abstracts from the American Heart Association Scientific Sessions 2005; November 13–16, 2005; Dallas, Texas. Late Breaking Clinical Trials II.
4. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial;Mebazaa;JAMA,2007
5. Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients;Parissis;Am J Cardiol,2007
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献